Chicago Trust’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,735
Closed -$989K 395
2025
Q4
$989K Hold
9,735
0.15% 122
2025
Q3
$533K Sell
9,735
-800
-8% -$40K 0.07% 241
2025
Q2
$560K Sell
10,535
-45
-0.4% -$2.29K 0.08% 221
2025
Q1
$458K Sell
10,580
-50
-0.5% -$2.53K 0.08% 223
2024
Q4
$597K Sell
10,630
-415
-4% -$25.8K 0.11% 174
2024
Q3
$752K Buy
11,045
+4,550
+70% +$257K 0.13% 151
2024
Q2
$274K Sell
6,495
-545
-8% -$30K 0.06% 259
2024
Q1
$486K Sell
7,040
-1,235
-15% -$78.1K 0.1% 185
2023
Q4
$612K Sell
8,275
-1,261
-13% -$82.7K 0.14% 155
2023
Q3
$651K Buy
9,536
+80
+0.8% +$6.79K 0.16% 143
2023
Q2
$888K Buy
9,456
+156
+2% +$12.2K 0.21% 124
2023
Q1
$631K Hold
9,300
0.16% 151
2022
Q4
$461K Buy
9,300
+500
+6% +$20.4K 0.12% 178
2022
Q3
$286K Hold
8,800
0.07% 227
2022
Q2
$347K Sell
8,800
-5,600
-39% -$299K 0.09% 209
2022
Q1
$1.01M Hold
14,400
0.22% 115
2021
Q4
$1.12M Buy
14,400
+5,000
+53% +$441K 0.22% 121
2021
Q3
$897K Buy
9,400
+6,900
+276% +$729K 0.2% 133
2021
Q2
$311K Buy
+2,500
New +$298K 0.07% 235

Other funds holding EXAS

Chicago Trust's EXAS Position: Q1 2026 in Review

Chicago Trust sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 9,735 shares — an estimated $989K sold.

Chicago Trust first reported a position in EXAS in Q2 2021 and held it in 19 quarters. The position peaked at $1.12M in Q4 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Chicago Trust reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Chicago Trust sold 9,735 Exact Sciences shares in Q1 2026, an estimated $989K.
  • Chicago Trust first reported a position in Exact Sciences in Q2 2021 and held it in 19 quarters.
  • Chicago Trust's Exact Sciences position peaked at $1.12M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Chicago Trust's 13F filing for Q1 2026, filed 24 Apr 2026.